Who Mounjaro is For Mounjaro is intended for adults with type 2 diabetes mellitus who require additional treatment beyond lifestyle modifications and other glucose-lowering medications
Supplementary information Supplementary Information (download DOCX This file contains Supplementary Methods used in the manuscript and Supplementary Table 2 with all primer sequences used in the manuscript
This is the playbook for longevity: start with a primary indication, prove safety and efficacy, and then expand to adjacent conditions that share the same root cause
An earlier Phase 3 trial in people with obesity and knee osteoarthritis, TRIUMPH-4, found an average weight loss of 28.7% at the same dose, alongside a reduction in joint pain
New study alert GLP-1 medications, yes - the ones often used for weight loss - may also reduce migraine frequency by up to 50% in patients with high-frequency or chronic migraine
Ready to explore peptide therapy in Denver